PMID- 17925029 OWN - NLM STAT- MEDLINE DCOM- 20080115 LR - 20211020 IS - 1471-2164 (Electronic) IS - 1471-2164 (Linking) VI - 8 DP - 2007 Oct 9 TI - Identification of genes that regulate multiple cellular processes/responses in the context of lipotoxicity to hepatoma cells. PG - 364 AB - BACKGROUND: In order to devise efficient treatments for complex, multi-factorial diseases, it is important to identify the genes which regulate multiple cellular processes. Exposure to elevated levels of free fatty acids (FFAs) and tumor necrosis factor alpha (TNF-alpha) alters multiple cellular processes, causing lipotoxicity. Intracellular lipid accumulation has been shown to reduce the lipotoxicity of saturated FFA. We hypothesized that the genes which simultaneously regulate lipid accumulation as well as cytotoxicity may provide better targets to counter lipotoxicity of saturated FFA. RESULTS: As a model system to test this hypothesis, human hepatoblastoma cells (HepG2) were exposed to elevated physiological levels of FFAs and TNF-alpha. Triglyceride (TG) accumulation, toxicity and the genomic responses to the treatments were measured. Here, we present a framework to identify such genes in the context of lipotoxicity. The aim of the current study is to identify the genes that could be altered to treat or ameliorate the cellular responses affected by a complex disease rather than to identify the causal genes. Genes that regulate the TG accumulation, cytotoxicity or both were identified by a modified genetic algorithm partial least squares (GA/PLS) analysis. The analyses identified NADH dehydrogenase and mitogen activated protein kinases (MAPKs) as important regulators of both cytotoxicity and lipid accumulation in response to FFA and TNF-alpha exposure. In agreement with the predictions, inhibiting NADH dehydrogenase and c-Jun N-terminal kinase (JNK) reduced cytotoxicity significantly and increased intracellular TG accumulation. Inhibiting another MAPK pathway, the extracellular signal regulated kinase (ERK), on the other hand, improved the cytotoxicity without changing TG accumulation. Much greater reduction in the toxicity was observed upon inhibiting the NADH dehydrogenase and MAPK (which were identified by the dual-response analysis), than for the stearoyl-CoA desaturase (SCD) activation (which was identified for the TG-alone analysis). CONCLUSION: These results demonstrate the applicability of GA/PLS in identifying the genes that regulate multiple cellular responses of interest and that genes regulating multiple cellular responses may be better candidates for countering complex diseases. FAU - Srivastava, Shireesh AU - Srivastava S AD - Department of Chemical Engineering and Material Science, Michigan State University, East Lansing, MI 48824, USA. srivas14@egr.msu.edu FAU - Li, Zheng AU - Li Z FAU - Yang, Xuerui AU - Yang X FAU - Yedwabnick, Matthew AU - Yedwabnick M FAU - Shaw, Stephen AU - Shaw S FAU - Chan, Christina AU - Chan C LA - eng GR - R01 GM079688/GM/NIGMS NIH HHS/United States GR - R21 CA126136/CA/NCI NIH HHS/United States GR - 1R01GM079688-01/GM/NIGMS NIH HHS/United States GR - 1R21CA126136-01/CA/NCI NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't PT - Research Support, U.S. Gov't, Non-P.H.S. DEP - 20071009 PL - England TA - BMC Genomics JT - BMC genomics JID - 100965258 RN - 0 (Fatty Acids, Nonesterified) RN - 0 (Triglycerides) RN - 0 (Tumor Necrosis Factor-alpha) RN - EC 1.6.99.3 (NADH Dehydrogenase) RN - EC 2.7.11.24 (Mitogen-Activated Protein Kinases) SB - IM MH - Algorithms MH - Fatty Acids, Nonesterified/*toxicity MH - *Gene Expression Profiling MH - Hepatoblastoma/genetics/*metabolism MH - Humans MH - Liver Neoplasms/genetics/*metabolism MH - Mitogen-Activated Protein Kinases/genetics MH - NADH Dehydrogenase/genetics MH - Triglycerides/metabolism MH - Tumor Cells, Cultured MH - Tumor Necrosis Factor-alpha/metabolism/toxicity PMC - PMC2110894 EDAT- 2007/10/11 09:00 MHDA- 2008/01/16 09:00 PMCR- 2007/10/09 CRDT- 2007/10/11 09:00 PHST- 2007/02/28 00:00 [received] PHST- 2007/10/09 00:00 [accepted] PHST- 2007/10/11 09:00 [pubmed] PHST- 2008/01/16 09:00 [medline] PHST- 2007/10/11 09:00 [entrez] PHST- 2007/10/09 00:00 [pmc-release] AID - 1471-2164-8-364 [pii] AID - 10.1186/1471-2164-8-364 [doi] PST - epublish SO - BMC Genomics. 2007 Oct 9;8:364. doi: 10.1186/1471-2164-8-364.